Ding Q - Search Results

1

Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma.

Butz H, Nofech-Mozes R, Ding Q, Khella HWZ, Szabó PM, Jewett M, Finelli A, Lee J, Ordon M, Stewart R, Krylov S, Yousef GM. Butz H, et al. Among authors: ding q. Eur Urol Focus. 2016 Jun;2(2):210-218. doi: 10.1016/j.euf.2015.11.006. Epub 2015 Dec 12. Eur Urol Focus. 2016. PMID: 28723537

2

An integrated genomic analysis of papillary renal cell carcinoma type 1 uncovers the role of focal adhesion and extracellular matrix pathways.

Wala SJ, Karamchandani JR, Saleeb R, Evans A, Ding Q, Ibrahim R, Jewett M, Pasic M, Finelli A, Pace K, Lianidou E, Yousef GM. Wala SJ, et al. Among authors: ding q. Mol Oncol. 2015 Oct;9(8):1667-77. doi: 10.1016/j.molonc.2015.04.007. Epub 2015 May 14. Mol Oncol. 2015. PMID: 26051997 Free PMC article.

3

miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma.

Khella HWZ, Butz H, Ding Q, Rotondo F, Evans KR, Kupchak P, Dharsee M, Latif A, Pasic MD, Lianidou E, Bjarnason GA, Yousef GM. Khella HWZ, et al. Among authors: ding q. Mol Ther. 2015 Nov;23(11):1748-1758. doi: 10.1038/mt.2015.129. Epub 2015 Jul 23. Mol Ther. 2015. PMID: 26201448 Free PMC article.

4

Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.

Saleeb RM, Plant P, Tawedrous E, Krizova A, Brimo F, Evans AJ, Wala SJ, Bartlett J, Ding Q, Boles D, Rotando F, Farag M, Yousef GM. Saleeb RM, et al. Among authors: ding q. Eur Urol Focus. 2018 Sep;4(5):740-748. doi: 10.1016/j.euf.2016.09.002. Epub 2016 Sep 22. Eur Urol Focus. 2018. PMID: 28753789

5

A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization.

Di Meo A, Saleeb R, Wala SJ, Khella HW, Ding Q, Zhai H, Krishan K, Krizova A, Gabril M, Evans A, Brimo F, Pasic MD, Finelli A, Diamandis EP, Yousef GM. Di Meo A, et al. Among authors: ding q. Oncotarget. 2017 Dec 8;9(2):2092-2104. doi: 10.18632/oncotarget.23162. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416756 Free PMC article.

6

Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis.

Butz H, Ding Q, Nofech-Mozes R, Lichner Z, Ni H, Yousef GM. Butz H, et al. Among authors: ding q. Oncotarget. 2017 Dec 8;9(4):4661-4674. doi: 10.18632/oncotarget.23163. eCollection 2018 Jan 12. Oncotarget. 2017. PMID: 29435133 Free PMC article.

7

The miR-200 family as prognostic markers in clear cell renal cell carcinoma.

Saleeb R, Kim SS, Ding Q, Scorilas A, Lin S, Khella HW, Boulos C, Ibrahim G, Yousef GM. Saleeb R, et al. Among authors: ding q. Urol Oncol. 2019 Dec;37(12):955-963. doi: 10.1016/j.urolonc.2019.08.008. Epub 2019 Oct 19. Urol Oncol. 2019. PMID: 31635993

8

Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance.

Lichner Z, Saleeb R, Butz H, Ding Q, Nofech-Mozes R, Riad S, Farag M, Varkouhi AK, Dos Santos CC, Kapus A, Yousef GM. Lichner Z, et al. Among authors: ding q. FASEB J. 2019 Jan;33(1):1347-1359. doi: 10.1096/fj.201800596R. Epub 2018 Aug 27. FASEB J. 2019. PMID: 30148679

In summary, we suggest that sunitinib-resistant RCC cells exist in treatment-sensitive tumors and are histologically identifiable.-Lichner, Z., Saleeb, R., Butz, H., Ding, Q., Nofech-Mozes, R., Riad, S., Farag, M., Varkouhi, A. K., dos Santos, C. C., Kapus, A., Yous …

In summary, we suggest that sunitinib-resistant RCC cells exist in treatment-sensitive tumors and are histologically identifiable.-Lichner, …

9

Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells.

Saleeb RM, Farag M, Ding Q, Downes M, Bjarnason G, Brimo F, Plant P, Rotondo F, Lichner Z, Finelli A, Yousef GM. Saleeb RM, et al. Among authors: ding q. Am J Pathol. 2019 Oct;189(10):2046-2060. doi: 10.1016/j.ajpath.2019.07.002. Epub 2019 Aug 2. Am J Pathol. 2019. PMID: 31381885 Free article.

10

Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.

Sidiropoulos KG, White NM, Bui A, Ding Q, Boulos P, Pampalakis G, Khella H, Samuel JN, Sotiropoulou G, Yousef GM. Sidiropoulos KG, et al. Among authors: ding q. Oncoscience. 2014 Oct 24;1(11):709-24. doi: 10.18632/oncoscience.91. eCollection 2014. Oncoscience. 2014. PMID: 25593998 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,752 results

Search Page

Filters